Cardiovascular medications and long‐term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (<scp>EMMA</scp>) — Karla A S Souza (2022) | RDL Network
Cardiovascular medications and long‐term mortality among stroke survivors in the Brazilian Study of Stroke Mortality and Morbidity (<scp>EMMA</scp>)
Article 2022 en
Authors
KS
Karla A S Souza
AV
Ana C Varella
RO
Rodrigo Díaz Olmos
Abstract
1 min read
The risk of all-cause mortality was reduced by 48% among those with ischemic stroke under continuous use of medications. Secondary prevention should be emphasized more strongly in clinical practice. Geriatr Gerontol Int 2022; 22: 715-722.
Eleni Korompoki, Peter U. Heuschmann, Kirsten Harvey, Cornelia Fießler, Uwe Malzahn, Klemens Hügen, Sabine Ullmann, Gabriele Putz Todd, Carolin Schuhmann, Joan Montaner, Igor Sibon, Stéphanie Debette, Christian Enzinger, Stefan Ropele, Viktoria Rücker, Kirsten Haas, Emily Harvey, Charles Wolfe, Yanzhong Wang, Peter Brønnum Nielsen, Valeria Caso, Professor Gregory Lip, Deirdre A. Lane, Omid Halse, Peter Ringleb, Walter E. Haefeli, Kathrin I. Foerster, Viktoria S. Wurmbach, Roland Veltkamp
Alessandra C. Goulart, A. C. Varella, Gisela Tunes da Silva, Airlane Pereira Alencar, Itamar S Santos, Carla Romagnolli, Tiffany E Gooden, G. Neil Thomas, Professor Gregory Lip, Rodrigo Díaz Olmos, Paulo A. Lotufo, Isabela M Benseñor
Inder S. Anand, Changhong Yu, Marc A. Pfeffer, John J.V. McMurray, Akshay S. Desai, Scott D. Solomon, Dirk J. ban Veldhuisen, Sunfa Cheng, Kurt Olson, Aldo Maggioni, Karl Swedberg, James B. Young
Discussion(0)
No comments yet. Be the first to comment.